Abstract
BackgroundIL-23 is considered to play an important role in the development of enthesitis. Ustekinumab (UST), a combined inhibitor of IL-12/IL-23 shows efficacy in psoriatic arthritis (PsA), which is driven by...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have